CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | Burke William Patrick Chief Human Resources Officer | Exercise or conversion | +1,402 | $21.60 | $30K | 51,269 |
| 2022-01-03 | Burke William Patrick Chief Human Resources Officer | Sale | −399 | $76.03 | $30K | 50,870 |
| 2022-01-03 | Burke William Patrick Chief Human Resources Officer | Exercise or conversion · Options to Buy Ordinary Shares | −17,452 | 0 | ||
| 2022-01-03 | Burke William Patrick Chief Human Resources Officer | Exercise or conversion · Options to Buy Ordinary Shares | −9,750 | 0 | ||
| 2022-01-03 | Burke William Patrick Chief Human Resources Officer | Exercise or conversion · Options to Buy Ordinary Shares | −1,402 | 6,098 | ||
| 2021-11-26 | Danziger Asaf Chief Executive Officer | Purchase | +3,870 | $102.36 | $396K | 12,172 |
| 2021-11-26 | Danziger Asaf Chief Executive Officer | Purchase | +1,000 | $103.37 | $103K | 13,172 |
| 2021-11-26 | Danziger Asaf Chief Executive Officer | Purchase | +104 | $96.50 | $10K | 13,276 |
| 2021-11-02 | Cordova Ashley Chief Financial Officer | Sale | −209 | $107.28 | $22K | 41,758 |
| 2021-09-03 | Shah Pritesh Chief Commercial Officer | Sale | −321 | $138.27 | $44K | 73,692 |
| 2021-09-03 | Shah Pritesh Chief Commercial Officer | Sale | −150 | $139.24 | $21K | 73,542 |
| 2021-09-03 | Shah Pritesh Chief Commercial Officer | Sale | −30 | $140.18 | $4K | 73,512 |
| 2021-09-02 | Leonard Frank X Chief Development Officer | Sale | −540 | $138.23 | $75K | 87,153 |
| 2021-09-02 | Cordova Ashley Chief Financial Officer | Sale | −828 | $138.23 | $114K | 41,967 |
| 2021-09-02 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Sale | −181 | $138.23 | $25K | 149,899 |
| 2021-09-02 | Shah Pritesh Chief Commercial Officer | Sale | −156 | $138.23 | $22K | 74,013 |
| 2021-08-12 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +10,000 | $15.60 | $156K | 45,993 |
| 2021-08-12 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +5,927 | $19.25 | $114K | 51,920 |
| 2021-08-12 | Cordova Ashley Chief Financial Officer | Sale | −5,927 | $141.06 | $836K | 45,993 |
| 2021-08-12 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +8,026 | $21.50 | $173K | 54,019 |
Page 25 of 32 · 638 trades